Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeRoock, I. B.
Right arrow Articles by Cress, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeRoock, I. B.
Right arrow Articles by Cress, A. E.
[Cancer Research 61, 3308-3313, April 15, 2001]
© 2001 American Association for Cancer Research


Carcinogenesis

Synthetic Peptides Inhibit Adhesion of Human Tumor Cells to Extracellular Matrix Proteins1

Ian B. DeRoock, Michael E. Pennington, Thomas C. Sroka, Kit S. Lam2, G. Tim Bowden, Elisabeth L. Bair and Anne E. Cress3

Department of Radiation Oncology [I. B. D. , M. E. P. , T. C. S., K. S. L., G. T. B., E. L. B.] and Department of Molecular and Cellular Biology and Department of Medicine [A. E. C.], The Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724-5024

Human tumor cell progression and metastasis are partially dependent on the ability of a tumor cell to adhere to the proteins of the extracellular matrix (ECM) and survive at the distant location. Six novel D-amino acid-containing peptides were analyzed for their ability to adhere to human prostate tumor cells, support tumor cell adhesion, and inhibit tumor cell adhesion to ECM proteins or human dermal fibroblasts. Of these, two peptides called RZ-3 (kmviywkag) and HYD-1 (kikmviswkg) bound to tumor cell surfaces and compared favorably with the previously reported AG-73 (RKRLQVQLSIRT) L-amino acid peptide, as determined by fluorescence-activated cell sorting analysis. A scrambled peptide derivative of HYD-1, called HYDS-1 (wiksmkivkg), was not active. The RZ-3, HYD-1, and AG-73 peptides supported maximal cancer cell adhesion at 5 µg, 10 µg, and 50 µg/well, respectively. The ECM proteins fibronectin, laminin 1, and collagen IV supported maximal cell adhesion at 1 µg, >10 µg, and 50 µg/well, respectively. Prostate tumor cell adhesion to immobilized RZ-3 and HYD-1 peptides was inhibited by {alpha}2–6- and ß1-integrin-blocking antibodies. Conversely, tumor cell adhesion to a ß1-integrin-specific antibody was blocked by both RZ-3 and HYD-1. Epithelial cell adhesion to dermal fibroblasts was inhibited by HYD-1 and unaffected by the scrambled peptide, HYDS-1. Cell adhesion to immobilized peptides was unaffected by EDTA. The soluble RZ-3 and HYD-1 peptides inhibited tumor cell adhesion to each of the immobilized four ECM proteins (1.0 µg/well) in a time- and concentration-dependent manner. The IC50 of the RZ-3 peptide for blocking adhesion to fibronectin, laminin 1, laminin 5, and collagen IV was 2.4 µg, 1.8 µg, 4.6 µg, and 2.8 µg/well, respectively. The IC50 of the HYD-1 peptide for blocking adhesion to fibronectin, laminin 1, laminin 5, and collagen IV was 6.9 µg, 5.7 µg, >10 µg, and 6.2 µg/well, respectively. Taken together, these results indicate that RZ-3 and HYD-1 are biologically active D-amino acid-containing peptides that can themselves support tumor cell adhesion and can inhibit tumor cell adhesion to immobilized ECM proteins or dermal fibroblasts.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
T. C. Sroka, M. E. Pennington, and A. E. Cress
Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5
Carcinogenesis, September 1, 2006; 27(9): 1748 - 1757.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. Thamilselvan and M. D. Basson
The role of the cytoskeleton in differentially regulating pressure-mediated effects on malignant colonocyte focal adhesion signaling and cell adhesion
Carcinogenesis, October 1, 2005; 26(10): 1687 - 1697.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-J. Leu, Y. Liu, N. Chen, C.-C. Chen, S. C.-T. Lam, and L. F. Lau
Identification of a Novel Integrin {alpha}6{beta}1 Binding Site in the Angiogenic Inducer CCN1 (CYR61)
J. Biol. Chem., September 5, 2003; 278(36): 33801 - 33808.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. H. Shain and W. S. Dalton
Cell Adhesion Is a Key Determinant in de Novo Multidrug Resistance (MDR): New Targets for the Prevention of Acquired MDR
Mol. Cancer Ther., November 1, 2001; 1(1): 69 - 78.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Nishimura, M. Adachi, T. Ishida, T. Matsunaga, H. Uchida, H. Hamada, and K. Imai
Adenovirus-mediated Transfection of Caspase-8 Augments Anoikis and Inhibits Peritoneal Dissemination of Human Gastric Carcinoma Cells
Cancer Res., October 1, 2001; 61(19): 7009 - 7014.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.